共 9 条
[1]
Witzig TE(2002)Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin’s lymphoma J Clin Oncol 20 2453-2463
[2]
Gorgon LI(2003)Future directions in radioimmunotherapy for B-cell lymphoma Semin Oncol 30 29-34
[3]
Cabanillas F(2001)Fulminant hepatitis B virus reactivation with concomitant listeriosis after fludarabine and rituximab therapy: case report Ann Hematol 80 549-552
[4]
Horning SJ(2003)Fatal hepatitis B virus reactivation by an escape mutant following rituximab therapy (letter) Blood 102 1930-undefined
[5]
Ng HJ(undefined)undefined undefined undefined undefined-undefined
[6]
Lim LC(undefined)undefined undefined undefined undefined-undefined
[7]
Westhoff TH(undefined)undefined undefined undefined undefined-undefined
[8]
Jochimsen F(undefined)undefined undefined undefined undefined-undefined
[9]
Schmittel A(undefined)undefined undefined undefined undefined-undefined